Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia

JAMA Dermatology

Volumn 150, Issue 3, 2014, Pages 280-287

  Velez, Nicole F ^a   Karia, Pritesh S ^a   Vartanov, Alexander R ^b   Davids, Matthew S ^b   Brown, Jennifer R ^b   Schmults, Chrysalyne D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CUTANEOUS MELANOMA; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LOW RISK POPULATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MERKEL CELL TUMOR; NON BASAL CELL CARCINOMA; PATIENT ASSESSMENT; PRIORITY JOURNAL; RAI STAGE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SKIN CANCER; SKIN CARCINOMA;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; ANALYSIS OF VARIANCE; BOSTON; CARCINOMA, MERKEL CELL; CARCINOMA, SQUAMOUS CELL; CAUSE OF DEATH; COHORT STUDIES; COMORBIDITY; CONFIDENCE INTERVALS; DISEASE PROGRESSION; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84896089825     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2013.6249     Document Type: Article

References (28)

1. Mehrany K, Byrd DR, Roenigk RK, et al. Lymphocytic infiltrates and subclinical epithelial tumor extension in patientswith chronic leukemia and solid-organ transplantation. Dermatol Surg. 2003;29(2):129-134. (Pubitemid 36188418)
2. Shanafelt TD, Byrd JC, Call TG, Zent CS, Kay NE. Narrative review: initial management of newly diagnosed, early-stage chronic lymphocytic leukemia. Ann Intern Med. 2006;145(6):435-447. (Pubitemid 46768575)
3. Kipps TJ. Chronic lymphocytic leukemia. Curr Opin Hematol. 2000;7(4):223-234. (Pubitemid 30387846)
4. Travis LB, Curtis RE, Hankey BF, Fraumeni JF Jr. Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst. 1992;84(18):1422-1427.
5. Royle JA, Baade PD, Joske D, Girschik J, Fritschi L. Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study. Br J Cancer. 2011;105(7):1076-1081.
6. Wiernik PH. Second neoplasms in patients with chronic lymphocytic leukemia. Curr Treat Options Oncol. 2004;5(3):215-223. (Pubitemid 39359622)
7. Molica S. Second neoplasms in chronic lymphocytic leukemia: incidence and pathogenesis with emphasis on the role of different therapies. Leuk Lymphoma. 2005;46(1):49-54.
8. Frierson HF Jr, Deutsch BD, Levine PA. Clinicopathologic features of cutaneous squamous cell carcinomas of the head and neck in patientswith chronic lymphocytic leukemia/small lymphocytic lymphoma. Hum Pathol. 1988;19(12):1397-1402. (Pubitemid 19027544)
9. Mehrany K,Weenig RH, PittelkowMR, Roenigk RK, Otley CC. High recurrence rates of basal cell carcinoma after Mohs surgery in patients with chronic lymphocytic leukemia. Arch Dermatol. 2004;140(8):985-988. (Pubitemid 39062650)
10. Mehrany K,Weenig RH, PittelkowMR, Roenigk RK, Otley CC. High recurrence rates of squamous cell carcinoma after Mohs' surgery in patients with chronic lymphocytic leukemia. Dermatol Surg. 2005;31(1):38-42. (Pubitemid 40094060)
11. Khezri F, Brewer JD, Weaver AL. Merkel cell carcinoma in the setting of chronic lymphocytic leukemia. Dermatol Surg. 2011;37(8):1100-1105.
12. Brewer JD, Shanafelt TD, Otley CC, et al. Chronic lymphocytic leukemia is associated with decreased survival of patients with malignant melanoma and Merkel cell carcinoma in a SEER population-based study. J Clin Oncol. 2012;30(8):843-849.
13. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood. 1975;46(2):219-234.
14. Shanafelt TD, Call TG. Current approach to diagnosis and management of chronic lymphocytic leukemia. Mayo Clin Proc. 2004;79(3):388-398. (Pubitemid 38269240)
15. Merkel cell carcinoma. In: Campton CC, Byrd DR, Garcia-Aguilar J, Kurtzman SH, Olawaiye A, Washington MK, eds. AJCC Cancer Staging Atlas: A Companion to the Seventh Editions of the AJCC Cancer Staging Manual and Handbook (Greene, AJCC Cancer Staging Atlas). New York, NY: Springer; 2012:371-383.
16. Melanoma of the skin. In: Campton CC, Byrd DR, Garcia-Aguilar J, Kurtzman SH, Olawaiye A, Washington MK, eds. AJCC Cancer Staging Atlas: A Companion to the Seventh Editions of the AJCC Cancer Staging Manual and Handbook (Greene, AJCC Cancer Staging Atlas). New York, NY: Springer; 2012:385-416.
17. Jambusaria-Pahlajani A, Kanetsky PA, Karia PS, et al. Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system. JAMA Dermatol. 2013;149(4):402-410.
18. Hallek M, Cheson BD, Catovsky D, et al; International Workshop on Chronic Lymphocytic Leukemia. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008;111(12):5446-5456.
19. Brantsch KD, Meisner C, Schönfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 2008;9(8):713-720.
20. Schmults CD, Karia PS, Carter JB, Han J, Qureshi AA. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. JAMA Dermatol. 2013;149(5):541-547.
21. Koljonen V, Kukko H, Pukkala E, et al. Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma. Br J Cancer. 2009;101(8):1444-1447.
22. Aslakson CJ, Lee G, Boomer JS, Gilman-Sachs A, KucukO, Beaman KD. Expression of regeneration and tolerance factor on B cell chronic lymphocytic leukemias: a possible mechanism for escaping immune surveillance. AmJ Hematol. 1999;61(1):46-52. (Pubitemid 29218177)
23. Cantwell M, Hua T, Pappas J, Kipps TJ. Acquired CD40-ligand deficiency in chronic lymphocytic leukemia. Nat Med. 1997;3(9):984-989. (Pubitemid 27391952)
24. Cooper JZ, Brown MD. Special concern about squamous cell carcinoma of the scalp in organ transplant recipients. Arch Dermatol. 2006;142(6):755-758.
25. Penn I, FirstMR. Merkel's cell carcinoma in organ recipients: report of 41 cases. Transplantation. 1999;68(11):1717-1721. (Pubitemid 30004803)
26. Matin RN, Mesher D, Proby CM, et al Skin Care in Organ Transplant Patients, Europe (SCOPE) Group. Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 cases. Am J Transplant. 2008;8(9):1891-1900.
27. Maio M, Di Giacomo AM, Robert C, Eggermont AM. Update on the role of ipilimumab in melanoma and first data on new combination therapies. Curr Opin Oncol. 2013;25(2):166-172.
28. UrosevicM, Maier T, Benninghoff B, Slade H, Burg G, Dummer R. Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo. Arch Dermatol. 2003;139(10):1325-1332. (Pubitemid 37248283)